MGLL
MGLL (monoglyceride lipase, also known as MAGL, MGL and HU-K5) is a serine hydrolase that converts monoacylglycerides to free fatty acids and glycerol. It hydrolyses the endocannabinoid 2-arachidonoylglycerol and so helps regulate endocannabinoid signalling. Browse Assay Genie's current range of MGLL research reagents below, or read on for the biology behind the target.
MGLL catalyses the conversion of monoacylglycerides to free fatty acids and glycerol. It also hydrolyses the endocannabinoid 2-arachidonoylglycerol, and through this activity contributes to the regulation of endocannabinoid signalling, nociception and the perception of pain. By controlling the levels of fatty acids that act as signalling molecules, the enzyme has also been reported to influence cancer cell migration, invasion and tumour growth.
The MGLL gene encodes a serine hydrolase of the AB hydrolase superfamily and belongs to the monoacylglycerol lipase family. The protein is found in the cytosol and associated with membranes. HGNC places it in the groups of lipases and 2-arachidonoylglycerol hydrolases, and its enzyme classification is EC 3.1.1.23. Mouse and rat both carry an orthologous Mgll gene, which allows the enzyme to be studied in common rodent models.
Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. Expression of MGLL may play a role in cancer tumorigenesis and metastasis, and its hydrolysis of 2-arachidonoylglycerol links it to pain biology. Aliases found in the literature include MAGL, MGL and HU-K5, so searches for an MGLL antibody, MGLL ELISA kit or MGLL protein may use any of these names.
MGLL hydrolyses 2-arachidonoylglycerol, making it a key enzyme for studying how endocannabinoid signalling is regulated.
Through its control of 2-arachidonoylglycerol, MGLL plays a critical role in nociception and the perception of pain.
MGLL regulates fatty acids that promote cancer cell migration, invasion and tumour growth, and its expression may affect tumorigenesis and metastasis.
MGLL converts monoacylglycerides to free fatty acids and glycerol, placing it in lipid hydrolysis and fatty acid signalling research.
MGLL is a serine hydrolase that converts monoacylglycerides to free fatty acids and glycerol. It hydrolyses the endocannabinoid 2-arachidonoylglycerol, contributing to the regulation of endocannabinoid signalling, nociception and pain perception, and it regulates fatty acids that act as signalling molecules.
MGLL stands for monoglyceride lipase and is also called monoacylglycerol lipase. Aliases include MAGL, MGL and HU-K5. The gene is annotated with EC 3.1.1.23, and alternative splicing produces transcript variants that encode multiple isoforms.
Mouse and rat each have an orthologous Mgll gene; check the datasheet of any product for its validated reactivity. MGLL expression may play a role in cancer tumorigenesis and metastasis, and its fatty acid products promote cancer cell migration, invasion and tumour growth.
Other lipases, endocannabinoid pathway enzymes and receptors, and lipid metabolism targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q99685; product specifications from Assay Genie datasheets.